{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:34:33Z","timestamp":1795196073467,"version":"4.10.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,8]]},"DOI":"10.7759\/cureus.57842","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T16:38:56Z","timestamp":1712594336000},"source":"Crossref","is-referenced-by-count":6,"title":["Cardiovascular Morbidity in Systemic Lupus Erythematosus: A Single-Center Retrospective Study"],"prefix":"10.7759","author":[{"given":"Yousef","family":"Alammari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahed A","family":"Albednah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid A","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman M","family":"Alrashoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz Y","family":"Alsharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah H","family":"Alkahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan  Z","family":"Alshehry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman  A","family":"Alajaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M","family":"Alsaedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Al harbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayan Abubakker","family":"Qutob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Almansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Systemic Lupus Erythematosus","author":"Justiz Vaillant AA","year":"2022","unstructured":"Justiz Vaillant AA, Goyal A, Varacallo M. Systemic Lupus Erythematosus. StatPearls, Treasure Island (FL); 2022."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1327352","article-title":"Epidemiology of systemic lupus erythematosus","volume":"13","author":"Pons-Estel GJ","year":"2017","unstructured":"Pons-Estel GJ, Ugarte-Gil MF, Alarc\u00f3n GS. Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol. 2017, 13:799-814. 10.1080\/1744666X.2017.1327352","journal-title":"Expert Rev Clin Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-019-00229-3","article-title":"Immunological pathogenesis and treatment of systemic lupus erythematosus","volume":"16","author":"Pan L","year":"2020","unstructured":"Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020, 16:19-30. 10.1007\/s12519-019-00229-3","journal-title":"World J Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer M","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al.. 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019, 71:1400-12. 10.1002\/art.40930","journal-title":"Arthritis Rheumatol"},{"key":"ref5","article-title":"","author":"Feather A","year":"2021","unstructured":"Feather A, Randall D, Waterhouse M. Kumar and Clark's Clinical Medicine. Feather A, Randall D, Waterhouse M (ed): Elsevier, 2021. https:\/\/www.us.elsevierhealth.com\/kumar-and-clarks-clinical-medicine-9780702078682.html."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2017-000221","article-title":"Associates and predictors of pleurisy or pericarditis in SLE","volume":"4","author":"Ryu S","year":"2017","unstructured":"Ryu S, Fu W, Petri MA. Associates and predictors of pleurisy or pericarditis in SLE. Lupus Sci Med. 2017, 4:e000221. 10.1136\/lupus-2017-000221","journal-title":"Lupus Sci Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4166","article-title":"Pericarditis in Lupus","volume":"11","author":"Dein E","year":"2019","unstructured":"Dein E, Douglas H, Petri M, Law G, Timlin H. Pericarditis in Lupus. Cureus. 2019, 11:e4166. 10.7759\/cureus.4166","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2008.08.010","article-title":"Pericarditis in systemic lupus erythematosus: prevalence and clinical and immunologic characteristics (Article in French)","volume":"38","author":"Smiti M","year":"2009","unstructured":"Smiti M, Salem TB, Larbi T, Sfaxi AB, Ghorbel IB, Lamloum M, Houman MH. Pericarditis in systemic lupus erythematosus: prevalence and clinical and immunologic characteristics (Article in French). Presse Med. 2009, 38:362-5. 10.1016\/j.lpm.2008.08.010","journal-title":"Presse Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2009.064311","article-title":"Cardiac pathology of systemic lupus erythematosus","volume":"62","author":"Jain D","year":"2009","unstructured":"Jain D, Halushka MK. Cardiac pathology of systemic lupus erythematosus. J Clin Pathol. 2009, 62:584-92. 10.1136\/jcp.2009.064311","journal-title":"J Clin Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2174\/157340308784245775","article-title":"Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors","volume":"4","author":"Zeller CB","year":"2008","unstructured":"Zeller CB, Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev. 2008, 4:116-22. 10.2174\/157340308784245775","journal-title":"Curr Cardiol Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216764","article-title":"Impact of the new American College of Cardiology\/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus","volume":"79","author":"Tselios K","year":"2020","unstructured":"Tselios K, Gladman DD, Su J, Urowitz M. Impact of the new American College of Cardiology\/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus. Ann Rheum Dis. 2020, 79:612-7. 10.1136\/annrheumdis-2019-216764","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-309561","article-title":"Incidence and risk of heart failure in systemic lupus erythematosus","volume":"103","author":"Kim CH","year":"2017","unstructured":"Kim CH, Al-Kindi SG, Jandali B, Askari AD, Zacharias M, Oliveira GH. Incidence and risk of heart failure in systemic lupus erythematosus. Heart. 2017, 103:227-33. 10.1136\/heartjnl-2016-309561","journal-title":"Heart"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.02.029","article-title":"Long-term cardiovascular outcomes in systemic lupus erythematosus","volume":"77","author":"Yafasova A","year":"2021","unstructured":"Yafasova A, Fosb\u00f8l EL, Schou M, et al.. Long-term cardiovascular outcomes in systemic lupus erythematosus. J Am Coll Cardiol. 2021, 77:1717-27. 10.1016\/j.jacc.2021.02.029","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000515","article-title":"Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study","volume":"8","author":"Samuelsson I","year":"2021","unstructured":"Samuelsson I, Parodis I, Gunnarsson I, Zickert A, Hofman-Bang C, Wall\u00e9n H, Svenungsson E. Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study. Lupus Sci Med. 2021, 8:10.1136\/lupus-2021-000515","journal-title":"Lupus Sci Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman MJ","year":"2003","unstructured":"Roman MJ, Shanker BA, Davis A, et al.. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003, 349:2399-406. 10.1056\/NEJMoa035471","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e31829dd857","article-title":"Atherosclerosis in systemic lupus erythematosus","volume":"62","author":"Stojan G","year":"2013","unstructured":"Stojan G, Petri M. Atherosclerosis in systemic lupus erythematosus. J Cardiovasc Pharmacol. 2013, 62:255-62. 10.1097\/FJC.0b013e31829dd857","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2007.06.003","article-title":"OxLDL\/beta2GPI-anti-oxLDL\/beta2GPI complex and atherosclerosis in SLE patients","volume":"7","author":"Bassi N","year":"2007","unstructured":"Bassi N, Ghirardello A, Iaccarino L, et al.. OxLDL\/beta2GPI-anti-oxLDL\/beta2GPI complex and atherosclerosis in SLE patients. Autoimmun Rev. 2007, 7:52-8. 10.1016\/j.autrev.2007.06.003","journal-title":"Autoimmun Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.121.315928","article-title":"Anti-dsDNA antibodies increase the cardiovascular risk in systemic lupus erythematosus promoting a distinctive immune and vascular activation","volume":"41","author":"Pati\u00f1o-Trives AM","year":"2021","unstructured":"Pati\u00f1o-Trives AM, P\u00e9rez-S\u00e1nchez C, P\u00e9rez-S\u00e1nchez L, et al.. Anti-dsDNA antibodies increase the cardiovascular risk in systemic lupus erythematosus promoting a distinctive immune and vascular activation. Arterioscler Thromb Vasc Biol. 2021, 41:2417-30. 10.1161\/ATVBAHA.121.315928","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani S","year":"2017","unstructured":"Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017, 12:825-35. 10.2215\/CJN.05780616","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v3.i4.156","article-title":"Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs","volume":"3","author":"Alani H","year":"2014","unstructured":"Alani H, Tamimi A, Tamimi N. Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World J Nephrol. 2014, 3:156-68. 10.5527\/wjn.v3.i4.156","journal-title":"World J Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43501","article-title":"Cardiovascular complications in lupus patients in the Aseer region, Saudi Arabia","volume":"15","author":"Alhammadi NA","year":"2023","unstructured":"Alhammadi NA, Alqahtani H, Alshahrani LH, et al.. Cardiovascular complications in lupus patients in the Aseer region, Saudi Arabia. Cureus. 2023, 15:e43501. 10.7759\/cureus.43501","journal-title":"Cureus"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107466","article-title":"Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: a systematic review and meta-analysis","volume":"94","author":"Lu X","year":"2021","unstructured":"Lu X, Wang Y, Zhang J, et al.. Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: a systematic review and meta-analysis. Int Immunopharmacol. 2021, 94:107466. 10.1016\/j.intimp.2021.107466","journal-title":"Int Immunopharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.14797\/mdcj-13-2-55","article-title":"Hypothyroidism and the heart","volume":"13","author":"Udovcic M","year":"2017","unstructured":"Udovcic M, Pena RH, Patham B, Tabatabai L, Kansara A. Hypothyroidism and the heart. Methodist Debakey Cardiovasc J. 2017, 13:55-9. 10.14797\/mdcj-13-2-55","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000579","article-title":"Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus","volume":"8","author":"Bolla E","year":"2021","unstructured":"Bolla E, Tentolouris N, Sfikakis PP, Tektonidou MG. Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus. Lupus Sci Med. 2021, 8:e000579. 10.1136\/lupus-2021-000579","journal-title":"Lupus Sci Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.09.007","article-title":"Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus","volume":"15","author":"Vivero F","year":"2016","unstructured":"Vivero F, Gonzalez-Echavarri C, Ruiz-Estevez B, Maderuelo I, Ruiz-Irastorza G. Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus. Autoimmun Rev. 2016, 15:1134-40. 10.1016\/j.autrev.2016.09.007","journal-title":"Autoimmun Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001464","article-title":"A meta-analysis and systematic review of valvular heart disease in systemic lupus erythematosus and its association with antiphospholipid antibodies","volume":"27","author":"Hussain K","year":"2021","unstructured":"Hussain K, Gauto-Mariotti E, Cattoni HM, Arif AW, Richardson C, Manadan A, Yadav N. A meta-analysis and systematic review of valvular heart disease in systemic lupus erythematosus and its association with antiphospholipid antibodies. J Clin Rheumatol. 2021, 27:e525-32. 10.1097\/RHU.0000000000001464","journal-title":"J Clin Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3373-z","article-title":"Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis","volume":"35","author":"Chen J","year":"2016","unstructured":"Chen J, Tang Y, Zhu M, Xu A. Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis. Clin Rheumatol. 2016, 35:2437-48. 10.1007\/s10067-016-3373-z","journal-title":"Clin Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.05.008","article-title":"Cardiovascular disease in systemic lupus erythematosus: a comprehensive update","volume":"82","author":"Giannelou M","year":"2017","unstructured":"Giannelou M, Mavragani CP. Cardiovascular disease in systemic lupus erythematosus: a comprehensive update. J Autoimmun. 2017, 82:1-12. 10.1016\/j.jaut.2017.05.008","journal-title":"J Autoimmun"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/antib5010002","article-title":"Autoantibodies in SLE: specificities, isotypes and receptors","volume":"5","author":"Dema B","year":"2016","unstructured":"Dema B, Charles N. Autoantibodies in SLE: specificities, isotypes and receptors. Antibodies (Basel). 2016, 5:2. 10.3390\/antib5010002","journal-title":"Antibodies (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","volume":"14","author":"Dima A","year":"2022","unstructured":"Dima A, Jurcut C, Chasset F, Felten R, Arnaud L. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. Ther Adv Musculoskelet Dis. 2022, 14:1759720X211073001. 10.1177\/1759720X211073001","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016040415","article-title":"Current and emerging therapies for lupus nephritis","volume":"27","author":"Parikh SV","year":"2016","unstructured":"Parikh SV, Rovin BH. Current and emerging therapies for lupus nephritis. J Am Soc Nephrol. 2016, 27:2929-39. 10.1681\/ASN.2016040415","journal-title":"J Am Soc Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/243900-cardiovascular-morbidity-in-systemic-lupus-erythematosus-a-single-center-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T16:39:00Z","timestamp":1712594340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/243900-cardiovascular-morbidity-in-systemic-lupus-erythematosus-a-single-center-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.57842","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,8]]}}}